"At AnMed Health Cancer Center, state-of-the-art technology and expert outpatient care are combined to provide nationally-recognized treatment. The Cancer Center offers a range of diagnostic and treatment services, including radiation therapy, infusion, chemotherapy and 3D mammography."

During the past decade, AnMed Health Cancer Center conducted 67 clinical trials. In the 10-year time frame, 67 clinical trials started and 71 clinical trials were completed, i.e. on average, 106% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 44 clinical trials were completed. i.e. 275% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AnMed Health Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 51 trials, followed by "SWOG Cancer Research Network" with 39 trials sponsored, "Alliance for Clinical Trials in Oncology" with 16 trials sponsored, "Gynecologic Oncology Group" with 10 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 10 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AnMed Health Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 94 trials as a collaborator, "NRG Oncology" with 25 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator and "Cancer and Leukemia Group B" with 3 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "AnMed Health Cancer Center" are "Breast Cancer" (12 trials), "Recurrent Ovarian Carcinoma" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Recurrent Fallopian Tube Carcinoma" (9 trials) and "Recurrent Primary Peritoneal Carcinoma" (8 trials). Many other conditions were trialed in "AnMed Health Cancer Center" in a lesser frequency.

Most popular intervention types in "AnMed Health Cancer Center" are "Drug" (120 trials), "Other" (99 trials), "Biological" (50 trials), "Procedure" (30 trials) and "Radiation" (24 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (56 trials), "Quality-of-Life Assessment" (36 trials), "Questionnaire Administration" (24 trials), "Paclitaxel" (22 trials) and "Carboplatin" (18 trials). Other intervention names were less common.

The vast majority of trials in "AnMed Health Cancer Center" are 99 trials for "All" genders, 45 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "AnMed Health Cancer Center". undefined are not yet recruiting, 16 are recruiting, 64 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 60 completed trials in AnMed Health Cancer Center, 1 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in AnMed Health Cancer Center, 3 "Phase 1" clinical trials were conducted, 63 "Phase 2" clinical trials and 83 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".